Obesity

Weight regain after behavioural weight management programmes and its impact on quality of life and cost effectiveness: Evidence synthesis and health economic analyses

Diabetes Obes MetabPublished Systematic review and meta-analysis of randomised trials with health economic analysis

Pooled result · Weight loss at programme endResult — go to the resultDifference −2.8 kg 95% CI −3.2 to −2.4

Authors' conclusion

Modest rates of weight regain, with persistent benefits for several years, should encourage health care practitioners and policymakers to offer obesity treatments that cost less than our suggested thresholds as a cost-effective intervention to improve long-term weight management.

Study context

Population
Adults with overweight/obesity in randomized trials of behavioural weight management programmes (BWMPs) reporting outcomes at ≥12 months and after programme end (search to December 2019)
Participants
> 150,000 adults155 trials
Comparison
BWMPs vs control
Outcome
Weight loss at programme end
Follow-up
Programme end
Methodological detailsmixed-effect, meta-regression and time-to-event models, health sector perspective cost-effectiveness
  • Mixed-effect, meta-regression and time-to-event models
  • Health sector perspective cost-effectiveness

Pooled result

As reported in the abstract

Difference

−2.8 kg

95% CI −3.2 to −2.4

Interventionvs Control
difference −2.8 kg (95% CI −3.2 to −2.4)
Weight regain after programme end greater in intervention vs control; between-group difference evident for at least 5 years
0.12-0.32 kg/year

Further pooled results

Quality of life

QoL increased in intervention vs control at programme end, then returned to control as weight difference diminished

Cost-effectiveness

BWMPs cost-effective if delivered per person for under
£560 (£8.80-£3900)

Longest follow-up

Longest follow-up post-programme
23 years

Original publication

Weight regain after behavioural weight management programmes and its impact on quality of life and cost effectiveness: Evidence synthesis and health economic analyses. Diabetes Obes Metab. Published 2 November 2022. doi:10.1111/dom.14895

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.